InvestorsHub Logo
Followers 0
Posts 28
Boards Moderated 0
Alias Born 05/08/2014

Re: None

Friday, 05/06/2016 5:16:45 PM

Friday, May 06, 2016 5:16:45 PM

Post# of 1689
Nearly all eggs in the basket with this one

Effective May 3, 2016, Dmitry Genkin resigned from of our board of directors. There was no known disagreement with Dr. Genkin on any matter relating to the Company’s operations, policies or practices. With Dr. Genkin’s resignation, the Company believes its board now consists of a majority of independent directors, which would be a requirement to list with the NASDAQ. This alteration of board structure was one of the actions required as part of the Company’s current NASDAQ application. Dr. Genkin will remain an observer on the Company’s board as well as maintain a scientific consulting role.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent XBIO News